Common Contracts

Licensing agreement for novel type 3 interferon

Licensing Agreement • September 23rd, 2020 • Delaware

• Contract Type
  Licensing Agreement
• Filed
  September 23rd, 2020
• Jurisdiction
  Delaware

THIS RELEASE AND LICENSE AGREEMENT (the “Agreement”) is made and entered into as of October 22, 2008 (the “Effective Date”) by and between ZymoGenetics, Inc. having offices at 1201 Eastlake Avenue East, Seattle, WA 98102-3702 (“ZymoGenetics”), and Bristol-Myers Squibb Company, a Delaware corporation having offices at Route 206 & Province Line Road, Princeton, NJ 08543 (“BMS”).